Exchange: NASDAQ·Updated 12:52 PM EDT
NYXH logo

NYXH Nyxoah SA

$1.70
$0.19
(12.58%)
Today
Reported EarningsAug 5
Mkt Cap$153.78M
Vol3.89M

About NYXH

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.
95

Extremely Bullish Sentiment

How do you feel about NYXH?

Advertisement|Remove ads.